Posts tagged patent
MSF OPEN LETTER TO TPP COUNTRIES
As negotiations for the Trans-Pacific Partnership Agreement continue in Malaysia, MSF urges negotiating countries to reject provisions that threaten to restrict access to affordable medicines. Read our open letter to the #TPP countries: http://ow.ly/n16Tb
The price of antiretroviral (ARV) drugs may have dropped around 99% over the past decade, but access to treatment remains an issue. Patents on new ARV drugs cause prices to skyrocket, making them unaffordable for people in low and middle-income countries.
Learn more in MSF Access Campaign’s 16th edition of Untangling the Web
0 plays
NPR reports on this week’s landmark ruling by India’s Supreme Court that means Indian generic drug manufacturers can keep producing affordable medicines for use in developing countries. Learn more about drug patents.
MSF & the Treatment Action Campaign rallied in front of the Africa IP Forum in Johannesburg, South Africa. We are calling for the South African government to fix its patent law to better protect access to affordable medicines.
MSF Launches Online Resource To Combat Unwarranted Drug Patent Requests
There are many reasons why people lack access to essential medicines, but one of the major barriers is the high price of drugs. Patents prevent the open competition that could drive prices down to lower, affordable levels. MSF Access Campaign launched an online database to help groups challenge unfair drug patents. Don’t give up. Keep up the fight!
Photo: Protesters carry signs outside Novartis’s Mumbai office on Worlds AIDS Day. India 2011 © Claudio Tommasini
Leena Menghaney: India’s Patent Law on Trial
In this piece from BMJ Group Blogs, lawyer and India manager of MSF’s Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India’s medicines patent law. Learn more at www.msfaccess.org